Integra LifeSciences Announces Changes Within Its Orthopedics and Tissue Technologies Business (press release)
Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that Mark Augusti has joined Integra as CVP, President, Orthopedics and Tissue Technologies. Mr. Augusti will be responsible for the management of our Spine and Extremities divisions, including strategic direction, portfolio management and evaluation of corporate development opportunities.
"I am pleased that Mark has become a member of our team," said Mr. Arduini, Integra's President and Chief Executive Officer. "With more than 25 years of experience in orthopedics, in particular, extremities and biologics, Mark brings a depth of general management experience and leadership that will be instrumental to our growth strategy."
One of Integra's strategic goals is accelerating growth. This organizational change provides Integra with the focus and expertise to accelerate growth in this important area of the business while advancing the Company's optimization goals. It will enable better trade-offs to be made around resources and investments at a divisional level. The creation of the integrated Orthopedics an...
